|
*Bravecto Topical
Solution for Cats kills fleas, prevents flea infestations, and kills
ticks (black-legged tick) for 12 weeks. Bravecto also kills American dog
ticks for 8 weeks.
|
IMPORTANT SAFETY INFORMATION:
The most common adverse reactions recorded in clinical trials were
vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy,
and scabs/ulcerated lesions. Bravecto has not been shown to be effective
for 12-weeks' duration in kittens less than 6 months of age. Bravecto
is not effective against American dog ticks beyond 8 weeks of dosing.
For topical use only. Avoid oral ingestion. The safety of Bravecto has
not been established in breeding, pregnant and lactating cats. Use with
caution in cats with a history of neurologic abnormalities. Neurologic
abnormalities have been reported in cats receiving Bravecto, even in
cats without a history of neurologic abnormalities.
|
VIEW PRESCRIBING INFORMATION
|
References: 1. Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016.
|
To opt-out of further Merck Animal Health communications click here. |
Copyright © 2017
Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck &
Co. Inc. All rights reserved.
|
|
|
|
|